CHEBI:69229 - caerulomycin J

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name caerulomycin J
Definition A pyridine alkaloid that is 2,2ʼ-bipyridine substituted by a hydroxy group at position 4 and an (acetylamino)methyl group at position 6. Isolated from the marine-derived actinomycete Actinoalloteichus cyanogriseus, it exhibits antineoplastic activity.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C13H13N3O2
Net Charge 0
Average Mass 243.26120
Monoisotopic Mass 243.10078
InChI InChI=1S/C13H13N3O2/c1-9(17)15-8-10-6-11(18)7-13(16-10)12-4-2-3-5-14-12/h2-7H,8H2,1H3,(H,15,17)(H,16,18)
SMILES CC(=O)NCc1cc(O)cc(n1)-c1ccccn1
Metabolite of Species Details
Actinoalloteichus cyanogriseus (NCBI:txid65497) Ethyl acetate extract of fermentation broth of strain WH1 2216-6 See: PubMed
Roles Classification
Biological Role(s): bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
marine metabolite
Any metabolite produced during a metabolic reaction in marine macro- and microorganisms.
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing caerulomycin J (CHEBI:69229) has parent hydride 2,2'-bipyridine (CHEBI:30351)
caerulomycin J (CHEBI:69229) has role antineoplastic agent (CHEBI:35610)
caerulomycin J (CHEBI:69229) has role bacterial metabolite (CHEBI:76969)
caerulomycin J (CHEBI:69229) has role marine metabolite (CHEBI:76507)
caerulomycin J (CHEBI:69229) is a acetamides (CHEBI:22160)
caerulomycin J (CHEBI:69229) is a bipyridines (CHEBI:50511)
caerulomycin J (CHEBI:69229) is a monohydroxypyridine (CHEBI:38182)
caerulomycin J (CHEBI:69229) is a pyridine alkaloid (CHEBI:26416)
Registry Number Type Source
21856156 Reaxys Registry Number Reaxys
Citation Waiting for Citations Type Source
21770434 PubMed citation Europe PMC
Last Modified
02 December 2013